REFERENCES
- Adams R H, Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat. Rev. Mol. Cell Biol 2007; 8(6)464–78
- Maruyama K, et al. Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J. Clin. Invest 2005; 115: 2363–2372
- Religa P, et al. Presence of bone marrow-derived circulating progenitor endothelial cells in the newly formed lymphatic vessels. Blood 2005; 106: 4184–4190
- Sebzda E, et al. Syk and Slp-76 mutant mice reveal a cell-autonomous hematopoietic cell contribution to vascular development. Dev. Cell 2006; 11: 349–361
- Hosking B, Makinen T. Lymphatic vasculature: A molecular perspective. Bioessays 2007; 29: 1192–1202
- Hong Y K, et al. Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate. Dev Dyn 2002; 225(3)351–357
- Wigle J T, et al. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO 2002; 21(7)1505–1513
- Karkkainen M J, et al. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol 2004; 5(1)74–80
- Karpanen T, et al. Lymphangiogenic growth factor responsiveness is modulated by postnatal lymphatic vessel maturation. Am. J. Pathol 2006; 169(2)708–718
- Streilein J W, et al. Anterior chamber-associated immune deviation, ocular immune privilege, and orthotopic corneal allografts. Transplant. Proc 1999; 31(3)1472–1475
- Dana M R, Streilein J W. Loss and restoration of immune privilege in eyes with corneal neovascularization. Invest. Ophthalmol. Vis. Sci 1996; 37(12)2485–2494
- Baluk P, McDonald D M. Markers for microscopic imaging of lymphangiogenesis and angiogenesis. Ann. N.Y. Acad. Sci 2008; 1131: 1–12
- Cursiefen C, et al. Lymphatic vessels in vascularized human corneas: Immunohistochemical investigation using LYVE-1 and podoplanin. Invest. Ophthalmol. Vis. Sci 2002; 43: 2127–2135
- Cursiefen C, et al. Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival. Invest. Ophthalmol. Vis. Sci 2004; 48(8)2666–2673
- Kerbel R, Folkman J. Clinical translation of angiogenesis inhibitors. Nat. Rev. Cancer 2002; 2(10)727–739
- Cursiefen C, et al. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J. Clin. Invest 2004; 113(7)1040–1050
- Dietrich T, et al. Inhibition of inflammatory lymphangiogenesis by integrin α 5 blockade. Am. J. Pathol 2007; 171(1)361–372
- Cursiefen C, et al. Time course of angiogenesis and lymphangiogenesis after brief corneal inflammation. Cornea 2006; 25(4)443–447
- Yamagami S, Dana M R. The critical role of lymph nodes in corneal alloimmunization and graft rejection. Invest. Ophthalmol. Vis. Sci 2001; 42(6)1293–1298
- Chen L, et al. Vascular endothelial growth factor receptor-3 mediates induction of corneal alloimmunity. Nat Med 2004; 10(8)813–815
- Chen L, et al. Very late antigen 1 blockade markedly promotes survival of corneal allografts. Arch. Ophthalmol 2007; 125(6)783–788